MFN2 and Friedreich ataxia: These results, along with those reported by other Drosophila FRDA models (Tricoire et al., 2014; Chen et al., 2016b), strongly question antioxidants as effective therapeutic agents in FRDA and highlight the relevance of protection mediated by Marf silencing.